These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 8641811)
41. T cell vaccination induces T cell receptor Vbeta-specific Qa-1-restricted regulatory CD8(+) T cells. Jiang H; Kashleva H; Xu LX; Forman J; Flaherty L; Pernis B; Braunstein NS; Chess L Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4533-7. PubMed ID: 9539772 [TBL] [Abstract][Full Text] [Related]
42. Quantification of a Selective Expansion of T Cell Receptor Vβ by Superantigen Using Real-Time PCR. Park JY; Seo KS Methods Mol Biol; 2016; 1396():167-180. PubMed ID: 26676047 [TBL] [Abstract][Full Text] [Related]
43. Staphylococcal enterotoxin H induces V alpha-specific expansion of T cells. Petersson K; Pettersson H; Skartved NJ; Walse B; Forsberg G J Immunol; 2003 Apr; 170(8):4148-54. PubMed ID: 12682246 [TBL] [Abstract][Full Text] [Related]
44. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation. Arad G; Levy R; Hillman D; Kaempfer R Nat Med; 2000 Apr; 6(4):414-21. PubMed ID: 10742148 [TBL] [Abstract][Full Text] [Related]
45. Biological properties of staphylococcal enterotoxin-like toxin type R. Omoe K; Imanishi K; Hu DL; Kato H; Takahashi-Omoe H; Nakane A; Uchiyama T; Shinagawa K Infect Immun; 2004 Jun; 72(6):3664-7. PubMed ID: 15155681 [TBL] [Abstract][Full Text] [Related]
46. A mutation of F47 to A in staphylococcus enterotoxin A activates the T-cell receptor Vbeta repertoire in vivo. Rosendahl A; Hansson J; Antonsson P; Sékaly RP; Kalland T; Dohlsten M Infect Immun; 1997 Dec; 65(12):5118-24. PubMed ID: 9393804 [TBL] [Abstract][Full Text] [Related]
47. Receptors on T cells escaping superantigen-mediated deletion lack special beta-chain junctional region structural characteristics. Pullen AM; Bogatzki LY J Immunol; 1996 Mar; 156(5):1865-72. PubMed ID: 8596038 [TBL] [Abstract][Full Text] [Related]
48. Localization of a T-cell epitope of superantigen toxic shock syndrome toxin 1 to residues 125 to 158. Hu WG; Zhu XH; Wu YZ; Jia ZC Infect Immun; 1998 Oct; 66(10):4971-5. PubMed ID: 9746605 [TBL] [Abstract][Full Text] [Related]
49. Human Keratinocyte Response to Superantigens. Schlievert PM; Gourronc FA; Leung DYM; Klingelhutz AJ mSphere; 2020 Oct; 5(5):. PubMed ID: 33028686 [No Abstract] [Full Text] [Related]
50. Differential reactivity of TCR Vbeta10 alleles to a mouse mammary tumor virus superantigen. Maillard I; Xenarios I; Diggelmann H; Orbea HA Eur J Immunol; 1998 Oct; 28(10):3075-85. PubMed ID: 9808176 [TBL] [Abstract][Full Text] [Related]
51. Evidence for a functional interaction between the beta chain of major histocompatibility complex class II and the T cell receptor alpha chain during recognition of a bacterial superantigen. Deckhut AM; Chien Y; Blackman MA; Woodland DL J Exp Med; 1994 Nov; 180(5):1931-5. PubMed ID: 7964468 [TBL] [Abstract][Full Text] [Related]
54. In vivo effects of a bacterial superantigen on macaque TCR repertoires. Kou ZC; Halloran M; Lee-Parritz D; Shen L; Simon M; Sehgal PK; Shen Y; Chen ZW J Immunol; 1998 May; 160(10):5170-80. PubMed ID: 9590270 [TBL] [Abstract][Full Text] [Related]
55. A serine/threonine phosphorylation site in the ectodomain of a T cell receptor beta chain is required for activation by superantigen. Lukashev DE; Caldwell CC; Chen P; Apasov SG; Margulies DH; Sitkovsky MV J Recept Signal Transduct Res; 2003 Feb; 23(1):33-52. PubMed ID: 12680588 [TBL] [Abstract][Full Text] [Related]
56. Analysis of superantigenic toxin Vbeta T-cell signatures produced during cases of staphylococcal toxic shock syndrome and septic shock. Ferry T; Thomas D; Perpoint T; Lina G; Monneret G; Mohammedi I; Chidiac C; Peyramond D; Vandenesch F; Etienne J Clin Microbiol Infect; 2008 Jun; 14(6):546-54. PubMed ID: 18373692 [TBL] [Abstract][Full Text] [Related]
57. T cell receptor V beta repertoire in mice lacking endogenous mouse mammary tumor provirus. Braun MY; Jouvin-Marche E; Marche PN; MacDonald HR; Acha-Orbea H Eur J Immunol; 1995 Mar; 25(3):857-62. PubMed ID: 7705418 [TBL] [Abstract][Full Text] [Related]
58. A single, engineered protein therapeutic agent neutralizes exotoxins from both Staphylococcus aureus and Streptococcus pyogenes. Wang N; Mattis DM; Sundberg EJ; Schlievert PM; Kranz DM Clin Vaccine Immunol; 2010 Nov; 17(11):1781-9. PubMed ID: 20861327 [TBL] [Abstract][Full Text] [Related]
59. Defense against biologic warfare with superantigen toxins. Kaempfer R; Arad G; Levy R; Hillman D Isr Med Assoc J; 2002 Jul; 4(7):520-3. PubMed ID: 12120463 [TBL] [Abstract][Full Text] [Related]
60. Evaluating the role of HLA-DQ polymorphisms on immune response to bacterial superantigens using transgenic mice. Rajagopalan G; Polich G; Sen MM; Singh M; Epstein BE; Lytle AK; Rouse MS; Patel R; David CS Tissue Antigens; 2008 Feb; 71(2):135-45. PubMed ID: 18086265 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]